Log in

Comment on: Patient out-of-pocket costs for guideline-recommended treatments for erectile dysfunction: a medicare cost modeling analysis

  • Comment
  • Published:
International Journal of Impotence Research Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

References

  1. Lyngdorf P, Hemmingsen L. Epidemiology of erectile dysfunction and its risk factors: a practice-based study in Denmark. Int J Impot Res. 2004;16:105–11.

    Article  CAS  PubMed  Google Scholar 

  2. Ciaccio V, Di Giacomo D. Psychological factors related to impotence as a sexual dysfunction in young men: a literature scan for noteworthy research frameworks. Clin Pract. 2022;12:501–12. https://doi.org/10.3390/clinpract12040054.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Nguyen V, McGovern AM, Rojanasarot S, Patel DP, Bhattacharyya S, Hargens LM. et al. Patient out-of-pocket costs for guideline-recommended treatments for erectile dysfunction: a medicare cost modeling analysis. Int. J. Impot. Res. 2024 https://doi.org/10.1038/s41443-024-00903-9.

  4. US Preventive Services Task Force. Collaboration and shared decision-making between patients and clinicians in preventive health care decisions and US Preventive Services Task Force Recommendations. JAMA. 2022;327:1171–6. https://doi.org/10.1001/jama.2022.3267.

    Article  Google Scholar 

  5. Sloan CE, Millo L, Gutterman S, Ubel PA. Accuracy of physician estimates of out-of-pocket costs for medication filling. JAMA Netw Open. 2021;4:e2133188. https://doi.org/10.1001/jamanetworkopen.2021.33188.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Santilli J, Vogenberg FR. Key strategic trends that impact healthcare decision-making and stakeholder roles in the new marketplace. Am Health Drug Benefits. 2015;8:15–20.

    PubMed  PubMed Central  Google Scholar 

  7. Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200:633–41. https://doi.org/10.1016/j.juro.2018.05.004.

    Article  PubMed  Google Scholar 

  8. Jiang JX, Krishnan R, Bai G. Price transparency in hospitals—current research and future directions. JAMA Netw Open. 2023;6:e2249588. https://doi.org/10.1001/jamanetworkopen.2022.49588.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed equally to manuscript. Authors RI and OAR contributed to analyzing data and writing manuscripts and references. Author OAR contributed and supervised the complete and final version of the manuscript and provided extensive revisions and final conclusions.

Corresponding author

Correspondence to Omer A. Raheem.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iwuala, R., Raheem, O.A. Comment on: Patient out-of-pocket costs for guideline-recommended treatments for erectile dysfunction: a medicare cost modeling analysis. Int J Impot Res (2024). https://doi.org/10.1038/s41443-024-00899-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41443-024-00899-2

  • Springer Nature Limited

Navigation